However, despite inducing high CSP-specific antibody responses that can protect human liver-chimeric mice against P. falciparum sporozoite challenge [39], RTS,S only confers moderate protection against clinical and severe disease in children and infants in malaria-endemic areas [6, 7]. This evidence concerns the gene DNAJC5 and malaria.